DIAGNOSTIC REPORT

MC-5746

PATIENT NAME : MRS. MONGLI SAREN REF. DOCTOR : DR. MMCH

CODE/NAME & ADDRESS : C000149746 ACCESSION NO : 0031XD016701 AGE/SEX : 46 Years Female
EXULT CARES PVT LTD PATIENT ID : MRSMF19047831 DRAWN : 19/04/2024 10:45:00
METROPOLITON, KOLKATA,SOUTH 24 PARGANAS
CLIENT PATIENT ID: RECEIVED : 19/04/2024 13:18:48
SOUTH 24 PARGANAS 700105
ABHA NO : REPORTED : 19/04/2024 19:12:45
9674885808

Test Report Status Final Results Biological Reference Interval Units

HAEMATOLOGY
CEREBROSPINAL FLUID, ROUTINE
CEREBROSPINAL FLUID ANALYSIS, CSF
VOLUME 0.5 mL
METHOD : MEASURED
APPEARANCE CLEAR CLEAR
METHOD : VISUAL
COLOUR WATERY
METHOD : VISUAL
XANTHOCHROMIA ABSENT ABSENT
METHOD : MANUAL
COB-WEB FORMATION ABSENT ABSENT
PROTEINS 52.8 High 15 - 45 mg/dL
METHOD : BENZETHONIUM CHLORIDE
GLUCOSE 63 40 - 70 mg/dL
METHOD : ENZYMATIC (HEXOKINASE/G-6-PDH)
TOTAL COUNT 05 0-5 cells / cumm

Comments

NOTE- OCCASIONAL LYMPHOCYTES SEEN.

Interpretation(s)
CEREBROSPINAL FLUID ANALYSIS, CSF-CSF Examination is performed to rule out and identify the cause of CNS and meningeal infection and inflammation. Presence of
RBCs in the CSF should also be correlated with the total cell count and the white cell count in CSF as contamination of CSF by blood may falsely alter the actual CSF cell
counts.

There is a dynamic equilibrium between blood and CSF glucose levels fluctuations in blood glucose parallel changes in the CSF. Hypoglycorrhachia (decreased CSF glucose)
can be masked by hyperglycemia, and lowered CSF glucose during hypoglycemia may be misinterpreted as meningitis. This misleading effect can be corrected by estimating
the CSF to blood glucose ratio, which derives a fairly constant value. The widely accepted normal ratio is between 0.6 and 0.8, although 0.5 has also been considered the
lower limit of normal. Less than this level indicates pathological hypoglycorrhachia..
Disclaimer: The counts may be inaccurate if the fluid specimen is partially clotted or has cell clumps or debris.

Page 1 Of 3

Dr.Anwesha Dr. Chaitali Ray, PHD

Chatterjee,MD,DipRCPath Chief Biochemist cum MRQA
(Histopathology)
Pathologist
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
P S Srijan Tech Park Building, Dn-52, Unit No. 2, Ground Floor, Sector V, Salt Lake,
Kolkata, 700091 ULR No.31000004985839-0031
West Bengal, India
Tel : 9111591115, Fax : 30203412
CIN - U74899PB1995PLC045956
Email : customercare.saltlake@agilus.in
 DIAGNOSTIC REPORT

MC-5746

PATIENT NAME : MRS. MONGLI SAREN REF. DOCTOR : DR. MMCH

CODE/NAME & ADDRESS : C000149746 ACCESSION NO : 0031XD016701 AGE/SEX : 46 Years Female
EXULT CARES PVT LTD PATIENT ID : MRSMF19047831 DRAWN : 19/04/2024 10:45:00
METROPOLITON, KOLKATA,SOUTH 24 PARGANAS
CLIENT PATIENT ID: RECEIVED : 19/04/2024 13:18:48
SOUTH 24 PARGANAS 700105
ABHA NO : REPORTED : 19/04/2024 19:12:45
9674885808

Test Report Status Final Results Biological Reference Interval Units

MICRO BIOLOGY
GRAM STAIN
SPECIMEN SOURCE CEREBROSPINAL FLUID
GRAM STAIN NO ORGANISMS DETECTED
METHOD : GRAM’S STAIN + MICROSCOPIC EXAMINATION

ACID FAST BACILLI SMEAR

SPECIMEN SOURCE CEREBROSPINAL FLUID
ACID FAST BACILLI SMEAR ACID FAST BACILLI
NOT DETECTED
METHOD : ZIEHL NEELSON'S METHOD

Interpretation(s)
GRAM STAIN-GRAM STAIN
Gram stain is the most important staining method in bacteriology. It is the first and usually the only method employed for the diagnostic identification of bacteria in clinical
specimens. It also serves to assess the quality of clinical specimens.Interpretation of gram stained smears from clinical specimens involves consideration of staining
characteristic,morphology of the etiological agent and presence of particular host cell types. It distinguishes two categories of genera: the Gram-positive, which stain dark
purple, and the Gram-negative, which stain light red. A few species are Gram-variable, and tend to show a mixture of the two types of cells. Further details of the bacteria
as any other special features, including unusual shapes (such as comma shaped Gram negative bacilli) are also observed. Comparing Gram stain result to culture results is
an excellent internal method for monitoring quality assurance.
ACID FAST BACILLI SMEAR-The direct smear microscopy is a reliable and simple technique for detection of AFB. The method consists of microscopic examination of a
specimen that has been spread on a slide and stained. Mycobacterial cell walls have a high lipid content that resists staining, however once stained, the bacterial cell resists
decolourisation by strong acids or alcohols. Hence these bacteria are known as ""acid - fast.""The sensitivity of microscopy for detection of acid fast bacilli is about 10,000
bacilli /ml. of the specimen. Many reports have shown that the mycobacteria may be released irregularly from the lungs. Thus, it is advisable to screen more than one
specimen.

Secretions build up in the airways overnight so an early morning sputum sample is more likely to contain AFB than a sample collected later in the day.
Organisms other than mycobacteria may demonstrate various degrees of acid fastness. Such organisms include Rhodococcus, Nocardia, Legionella and cysts of
Cryptosporidium and Isospora species.

**End Of Report**
Please visit www.agilusdiagnostics.com for related Test Information for this accession

Page 2 Of 3

Dr.Himadri Mondal, MD
Consultant Microbiologist

View Details View Report

PERFORMED AT :
Agilus Diagnostics Ltd
P S Srijan Tech Park Building, Dn-52, Unit No. 2, Ground Floor, Sector V, Salt Lake,
Kolkata, 700091 ULR No.31000004985839-0031
West Bengal, India
Tel : 9111591115, Fax : 30203412
CIN - U74899PB1995PLC045956
Email : customercare.saltlake@agilus.in
 DIAGNOSTIC REPORT

MC-5746

PATIENT NAME : MRS. MONGLI SAREN REF. DOCTOR : DR. MMCH

CODE/NAME & ADDRESS : C000149746 ACCESSION NO : 0031XD016701 AGE/SEX : 46 Years Female
EXULT CARES PVT LTD PATIENT ID : MRSMF19047831 DRAWN : 19/04/2024 10:45:00
METROPOLITON, KOLKATA,SOUTH 24 PARGANAS
CLIENT PATIENT ID: RECEIVED : 19/04/2024 13:18:48
SOUTH 24 PARGANAS 700105
ABHA NO : REPORTED : 19/04/2024 19:12:45
9674885808

Test Report Status Final Results Biological Reference Interval Units

CONDITIONS OF LABORATORY TESTING & REPORTING

1. It is presumed that the test sample belongs to the patient 5. AGILUS Diagnostics confirms that all tests have been
named or identified in the test requisition form.
2. All tests are performed and reported as per the
turnaround time stated in the AGILUS Directory of Services.
3. Result delays could occur due to unforeseen
circumstances such as non-availability of kits / equipment
breakdown / natural calamities / technical downtime or any
other unforeseen event.
4. A requested test might not be performed if:
i. Specimen received is insufficient or inappropriate
ii. Specimen quality is unsatisfactory
iii. Incorrect specimen type
iv. Discrepancy between identification on specimen
container label and test requisition form
performed or assayed with highest quality standards, clinical
safety & technical integrity.
6. Laboratory results should not be interpreted in isolation;
it must be correlated with clinical information and be
interpreted by registered medical practitioners only to
determine final diagnosis.
7. Test results may vary based on time of collection,
physiological condition of the patient, current medication or
nutritional and dietary changes. Please consult your doctor
or call us for any clarification.
8. Test results cannot be used for Medico legal purposes.
9. In case of queries please call customer care
(91115 91115) within 48 hours of the report.
.
Agilus Diagnostics Ltd
Fortis Hospital, Sector 62, Phase VIII,
Mohali 160062

Page 3 Of 3

Dr.Himadri Mondal, MD
Consultant Microbiologist

View Details View Report

PERFORMED AT :
Agilus Diagnostics Ltd
P S Srijan Tech Park Building, Dn-52, Unit No. 2, Ground Floor, Sector V, Salt Lake,
Kolkata, 700091 ULR No.31000004985839-0031
West Bengal, India
Tel : 9111591115, Fax : 30203412
CIN - U74899PB1995PLC045956
Email : customercare.saltlake@agilus.in